Tailored contact brachytherapy for challenging facial basal cell carcinomas: clinical results of 3D printing technology implementation
Reports of Practical Oncology and Radiotherapy · 06.05.2026 · 31 (2) · 279-288
DOI: 10.5603/rpor.110810 ↗Kurz gefasst
Fachartikel in der Zeitschrift Reports of Practical Oncology and Radiotherapy, online erschienen am 06.05.2026. Verfasst von Artur J Chyrek und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Brachytherapy, Greater Poland Cancer Centre, Poznan, Poland. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Basal cell carcinoma (BCC) often arises on cosmetically and functionally sensitive facial sites where standard contact brachytherapy applicators may not conform optimally. Patient-specific, 3D-printed surface applicators may improve geometric conformity, reduce air gaps, and enhance dose reproducibility. We report outcomes of individualized 3D-printed contact high-dose-rate brachytherapy (HDR-BT) for challenging facial BCC. Materials and methods: In this single-institution retrospective study, patients with histologically confirmed facial BCC in curved or irregular sites were treated with customized 3D-printed surface applicators. A planning computed tomography (CT) obtained with the applicator in situ guided contouring and optimization. Treatment was delivered with an Ir-192 HDR afterloader to 42-45 Gy in 6-11 fractions. Patients were evaluated at 4 weeks and then every 3-6 months. Primary endpoints were complete response (CR) and local control (LC); toxicity was graded per Radiation Therapy Oncology Group/European Organisation for Research and Treatment of Cancer (RTOG/EORTC) scale.
Results
Twenty-six patients (31 lesions; median age 77 years) were treated: T1 77%, T2 13%, T3 10%. Sites: nose 81%, peri-orbital 13%, ear 6%; 58% primary, 42% postoperative recurrences. At a median follow-up of 32 months, CR and LC were 100%. Acute reactions were mainly grade 1-2 skin changes; higher-grade events were transient. Late toxicity comprised grade 1 discoloration/hypopigmentation in 52% and grade 2 telangiectasia in 23%; 25% had no late toxicity. No grade ≥ 3 late events occurred.
Conclusions
Individualized 3D-printed contact applicators yielded excellent tumor control with low late toxicity in complex facial BCC. These practice-oriented data support wider implementation of personalized applicators in surface HDR-BT and encourage prospective validation in multicenter settings.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Brachytherapy, Greater Poland Cancer Centre, Poznan, Poland.
- Department of Electroradiology, Poznan University of Medical Sciences, Poznan, Poland.
- Department of Medical Physics, Greater Poland Cancer Centre, Poznan, Poland.
Zitieren
APA
Chyrek, A. J., Bielęda, G., Kluska, A., Burchardt, W. M., & Chicheł, A. (2026). Tailored contact brachytherapy for challenging facial basal cell carcinomas: clinical results of 3D printing technology implementation. Reports of Practical Oncology and Radiotherapy, 31(2), 279-288. https://doi.org/10.5603/rpor.110810
Vancouver
Chyrek AJ, Bielęda G, Kluska A, Burchardt WM, Chicheł A. Tailored contact brachytherapy for challenging facial basal cell carcinomas: clinical results of 3D printing technology implementation. Reports of Practical Oncology and Radiotherapy. 2026;31(2):279-288. doi:10.5603/rpor.110810
BibTeX
@article{Chyrek2026,
author = {Chyrek, Artur J and Bielęda, Grzegorz and Kluska, Adam and Burchardt, Wojciech M and Chicheł, Adam},
title = {Tailored contact brachytherapy for challenging facial basal cell carcinomas: clinical results of 3D printing technology implementation},
journal = {Reports of Practical Oncology and Radiotherapy},
year = {2026},
volume = {31},
number = {2},
pages = {279--288},
doi = {10.5603/rpor.110810}
}
EUVIMED